Fresh analysis suggests that people who stop using blockbuster slimming jabs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who stop conventional diet and exercise plans.
Findings released in a major health publication demonstrates that while overweight individuals can lose substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month once they quit.
"Users using these treatments need to be informed of the risk of fast rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.
That rate of recovery implies a return to original mass within about 18 months.
Comparing Treatments
The study, which reviewed 37 of trials involving thousands of participants, compared the results of the injectable medications with other pills.
Researchers note that people who shed pounds through lifestyle changes alone typically see a slower creep back—approximately 100 grams monthly—after stopping.
The Reason for the Rapid Rebound
Experts believe the mode of action of the drugs explains the accelerated rebound.
The injections copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing the hormone levels several times higher than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' means appetite is unsuppressed, making binge eating a significant risk."
An Ongoing Issue?
The NHS advise the jabs for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
A number of clinicians contend that, considering the high risk of relapse, the treatment is often life-long.
This opinion is reinforced by drug manufacturers, who state that the findings "underscore the persistent character of obesity," comparing it to managing conditions like hypertension.
User Testimonies
Users who have discontinued the medication describe a powerful return of hunger.
"It felt as if a switch flipping and you're instantly starving," said one woman.
This challenge is compounded if individuals have not adopted permanent lifestyle or habit modifications during therapy.
Widespread Use
Survey data suggest that a significant number of adults in the UK have used these injections in the past year, with demand being substantial.
- Adoption is higher among females than men.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, researchers caution that while these medications are powerful tools for shedding pounds, they are not a standalone solution and maintained weight loss relies on ongoing lifestyle changes.
